Warfarin might raise the risk of joint replacement: study
The analysis in people with AF suggests a NOAC might be the better option for those at risk of osteoarthritis, authors say.
Tag: Conference coverage
JAK inhibitor ‘safe and effective’ for RA over 20 months
Extension trial in patients with inadequate response to methotrexate finds no new safety signals, researchers report.
Hydroxychloroquine shortages ‘hit patient health’
Up to a quarter of rheumatology patients were disadvantaged in some regions, a global survey suggests.
Steroid injections ‘don’t hasten progression of knee OA’
Patients can be reassured that the treatment will not precipitate the need for surgery, researchers say.Â
Hydroxychloroquine cardiac scare ‘debunked’
The study in patients with rheumatoid arthritis and lupus finds no association with prolonged QT interval.
Methotrexate ‘might benefit’ knee OA with inflammation
The agent could be considered if usual treatment fails, researchers say after a randomised trial.Â
RA ‘linked with fracture risk’ in women
The disease itself might increase risk, independent of corticosteroid medications, authors say.
Few children with rheumatic disease contract COVID-19: study
Global survey suggests it's safe to continue immunosuppressive drugs, researchers say.
Lorlatinib ‘highly effective option’ for certain NSCLC patients
A head-to head trial shows it might be particularly effective in preventing intracranial progression, researchers say.
Setback for improved therapy in advanced urothelial cancer
Neither mono nor dual immune checkpoint inhibitor therapy improved survival in multi-nation study.
